CONMED (CNMD)
(Delayed Data from NYSE)
$71.00 USD
+0.40 (0.57%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $71.01 +0.01 (0.01%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CNMD 71.00 +0.40(0.57%)
Will CNMD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CNMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNMD
Conmed (CNMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock?
Henry Schein (HSIC) Down 4.3% Since Last Earnings Report: Can It Rebound?
Merit Medical (MMSI) Up 5% Since Last Earnings Report: Can It Continue?
Other News for CNMD
CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024
AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation
Clearmind secures exclusive rights to potential PSTD therapies
Warning: CNMD is at high risk of performing badly
Conmed Announces Executive Transition and New Officer Compensation